222 related articles for article (PubMed ID: 36208906)
1. Prevalence and outcomes of Covid-19 in Parkinson's disease: Acute settings and hospital.
Fearon C; Fasano A
Int Rev Neurobiol; 2022; 165():35-62. PubMed ID: 36208906
[TBL] [Abstract][Full Text] [Related]
2. The impact of Parkinson's disease on manifestations and outcomes of Covid-19 patients: A systematic review and meta-analysis.
El-Qushayri AE; Ghozy S; Reda A; Kamel AMA; Abbas AS; Dmytriw AA
Rev Med Virol; 2022 Mar; 32(2):e2278. PubMed ID: 34260773
[TBL] [Abstract][Full Text] [Related]
3. Parkinson's disease and COVID-19: a systematic review and meta-analysis.
Khoshnood RJ; Zali A; Tafreshinejad A; Ghajarzadeh M; Ebrahimi N; Safari S; Mirmosayyeb O
Neurol Sci; 2022 Feb; 43(2):775-783. PubMed ID: 34787753
[TBL] [Abstract][Full Text] [Related]
4. Clinical features and outcomes of hospitalised patients with COVID-19 and Parkinsonian disorders: A multicentre UK-based study.
Sorrell L; Leta V; Barnett A; Stevens K; King A; Inches J; Kobylecki C; Walker R; Chaudhuri KR; Martin H; Rideout J; Sneyd JR; Campbell S; Carroll C;
PLoS One; 2023; 18(7):e0285349. PubMed ID: 37523365
[TBL] [Abstract][Full Text] [Related]
5. Parkinson's Disease and the COVID-19 Pandemic.
Fearon C; Fasano A
J Parkinsons Dis; 2021; 11(2):431-444. PubMed ID: 33492244
[TBL] [Abstract][Full Text] [Related]
6. Covid-19 in Parkinson's Disease treated by drugs or brain stimulation.
Salari M; Etemadifar M; Zali A; Aminzade Z; Navalpotro-Gomez I; Tehrani Fateh S
Neurologia (Engl Ed); 2024 Apr; 39(3):254-260. PubMed ID: 38553103
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and impact of COVID-19 in Parkinson's disease: evidence from a multi-center survey in Tuscany region.
Del Prete E; Francesconi A; Palermo G; Mazzucchi S; Frosini D; Morganti R; Coleschi P; Raglione LM; Vanni P; Ramat S; Novelli A; Napolitano A; Battisti C; Giuntini M; Rossi C; Menichetti C; Ulivelli M; De Franco V; Rossi S; Bonuccelli U; Ceravolo R;
J Neurol; 2021 Apr; 268(4):1179-1187. PubMed ID: 32880722
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 manifestations in people with Parkinson's disease: a USA cohort.
Xu Y; Surface M; Chan AK; Halpern J; Vanegas-Arroyave N; Ford B; Feeney MP; Kwei KT; Katus LE; Kuo SH; Shah H; Waters C; Winfield LM; Beck JC; Przedborski S; Fahn S; Alcalay RN
J Neurol; 2022 Mar; 269(3):1107-1113. PubMed ID: 34482434
[TBL] [Abstract][Full Text] [Related]
9. Covid-19 and Parkinson's disease: an overview.
Cartella SM; Terranova C; Rizzo V; Quartarone A; Girlanda P
J Neurol; 2021 Dec; 268(12):4415-4421. PubMed ID: 34313818
[TBL] [Abstract][Full Text] [Related]
10. [Risk and course of COVID-19 in patients with Parkinson's disease].
Zalyalova ZA; Khasanova DM
Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(9):152-156. PubMed ID: 34693704
[TBL] [Abstract][Full Text] [Related]
11. Parkinson's disease may worsen outcomes from coronavirus disease 2019 (COVID-19) pneumonia in hospitalized patients: A systematic review, meta-analysis, and meta-regression.
Putri C; Hariyanto TI; Hananto JE; Christian K; Situmeang RFV; Kurniawan A
Parkinsonism Relat Disord; 2021 Jun; 87():155-161. PubMed ID: 33931304
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 and Parkinson's Disease: Possible Links in Pathology and Therapeutics.
Tiwari S; Yadav N; Singh S
Neurotox Res; 2022 Oct; 40(5):1586-1596. PubMed ID: 35829997
[TBL] [Abstract][Full Text] [Related]
13. The effects of Alzheimer's and Parkinson's disease on 28-day mortality of COVID-19.
Fathi M; Taghizadeh F; Mojtahedi H; Zargar Balaye Jame S; Markazi Moghaddam N
Rev Neurol (Paris); 2022; 178(1-2):129-136. PubMed ID: 34556345
[TBL] [Abstract][Full Text] [Related]
14. Parkinson's disease and Covid-19: The effect and use of telemedicine.
Podlewska AM; van Wamelen DJ
Int Rev Neurobiol; 2022; 165():263-281. PubMed ID: 36208904
[TBL] [Abstract][Full Text] [Related]
15. The Cause and Duration of Emergency Admissions to Hospital in People with Idiopathic Parkinson's Disease, Under the Care of a UK Service, During the First Year of the COVID-19 Pandemic.
Ellis PK; Davies ML; Gray WK; Barber M; Bolnykh I; Sadler M; Walker RW
J Parkinsons Dis; 2022; 12(6):1833-1840. PubMed ID: 35634853
[TBL] [Abstract][Full Text] [Related]
16. Links between COVID-19 and Parkinson's disease/Alzheimer's disease: reciprocal impacts, medical care strategies and underlying mechanisms.
Huang P; Zhang LY; Tan YY; Chen SD
Transl Neurodegener; 2023 Jan; 12(1):5. PubMed ID: 36717892
[TBL] [Abstract][Full Text] [Related]
17. Risk of Hospitalization and Death for COVID-19 in People with Parkinson's Disease or Parkinsonism.
Vignatelli L; Zenesini C; Belotti LMB; Baldin E; Bonavina G; Calandra-Buonaura G; Cortelli P; Descovich C; Fabbri G; Giannini G; Guarino M; Pantieri R; Samoggia G; Scaglione C; Trombetti S; D'Alessandro R; Nonino F;
Mov Disord; 2021 Jan; 36(1):1-10. PubMed ID: 33196119
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 and Parkinson's disease: a systematic review and meta-analysis.
Afraie M; Moradi G; Mohammadzedeh P; Azami M; Riyahifar S; Moradi Y
Acta Neurol Belg; 2023 Aug; 123(4):1209-1223. PubMed ID: 36385247
[TBL] [Abstract][Full Text] [Related]
19. Parkinson's disease patients may have higher rates of Covid-19 mortality in Iran.
Salari M; Etemadifar M; Ashrafi F; Ommi D; Aminzade Z; Tehrani Fateh S
Parkinsonism Relat Disord; 2021 Aug; 89():90-92. PubMed ID: 34256334
[TBL] [Abstract][Full Text] [Related]
20. The impact of SARS-COV2 infection on people in residential care with Parkinson Disease or parkinsonisms: Clinical case series study.
Sorbera C; Brigandì A; Cimino V; Bonanno L; Ciurleo R; Bramanti P; Di Lorenzo G; Marino S
PLoS One; 2021; 16(5):e0251313. PubMed ID: 33956891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
